Based in the United States, b-12 is a startup. Brouky records 1 investor associated with the company.
b-12 develops AI-powered software and services to design, optimize, and execute complex chemical syntheses, accelerating pharmaceutical research and development by automating retrosynthesis planning, reaction optimization, and lab automation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.